Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population

Biomarkers

Volumn 15, Issue 1, 2010, Pages 61-68

  Kohaar, Indu ^a   Kumar, J ^b   Thakur, Nisha ^a   Hussain, Showket ^a   Niyaz, Md Kausar ^a   Das, Bhudev C ^a   Sengupta, Shantanu ^b   Bharadwaj, Mausumi ^a  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Cervical cancer; Homocysteine; Human papilloma virus; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLIC ACID DEFICIENCY; GENE LINKAGE DISEQUILIBRIUM; HUMAN; INDIAN; MAJOR CLINICAL STUDY; PRECANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; INDIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 75749086766     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903295881     Document Type: Article

References (52)

1. Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock GW, Helzlsouer KJ. (2000). The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiology Biomarkers and Prevention 9:761-764
2. Allegra CJ, Fine RL, Drake JC, Chabner BA. (1986). The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis. J Cell Biochem 261:6478-6485
3. Angeline T, Jeyaraj N, Granito S, Tsongalis GJ. (2004). Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol 77:85-88
4. Botto LD, Yang Q. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877
5. Butterworth CE. (2000). Effect of total plasma homocysteine on cervical dysplasia risk. Nutr Cancer 37:128-133
6. Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. (2003). Methionine dependency and cancer treatment. Cancer Treat Rev 29:489-499
7. Chou YC, Lee MS, Wu MH, Shih HL, Yang T, Yu CP, Yu JC, Sun CA. (2007). Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat 101:199-205. (Pubitemid 46115426)
8. Cohen J. (2005). Public health. High hopes and dilemmas for a cervical cancer vaccine. Science 308:618-621
9. Corona G, Toffoli G, Fabris M, Viel A, Zarrelli A, Donada C, Boiocchi M. (1997). Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. Eur J Cancer 33:1284-1290
10. Das BC, Gopalkrishna V, Hedau S, Katiyar S. (2000). Cancer of the uterine cervix and human papillomavirus infection. Curr Sci 77:101-111
11. Eleftheriadou A, Chalastras T, Ferekidou E, Yiotakis I, Kyriou L, Tzagarakis M, Ferekidis E, Kandiloros D. (2006). Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine. Anticancer Res 26:2345-2348
12. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE. (2001). European Concerted Action Project. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 103:2544-2549
13. Fowler BM, Giuliano AR, Piyathilake C, Nour M, Hatch K. (1998). Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev 7:901-906
14. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Munoz N, Meijer CJ, Herrero R. (2003). Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 107:127-133
15. García-Closas R, Castellsagué X, Bosch X, González CA. (2005). The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 117:629-637
16. Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI, Rader JS. (2003). A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 90:560-565
17. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E. (2000). Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36:2313-2316
18. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S, Donlon TA. (2001). Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10:1275-1280
19. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Selhub J. (2000). Case-control study of plasma folate, homocysteine, vitamin B12, and cysteine as markers of cervical dysplasia. Cancer (Phila) 89:376-382
20. Hausen HZ. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350
21. Henao OL, Piyathilake CJ, Waterbor JW, Funkhouser E, Johanning GL, Heimburger DC, Partridge EE. (2005). Women with polymorphisms of methylenetetrahydrofolate Reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3. Int J Cancer 113:991-997
22. Jacob N, Bruckert E, Giral P, Foglietti MJ, Turpin G. (1999). Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis 146:53-59
23. Ji AJ, Savon SR, Jacobsen DW. (1995). Determination of total serum sulfite by HPLC with fluorescence detection. Clin Chem 41:897-903.
24. Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP. (2005). Polymorphism in folate-and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96:173-180
25. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M. (2007). TNFα-308G/A polymorphism as a risk factor for HPV-associated cervical cancer in Indian population. Cell Oncol 29:249-256
26. Kumar A, John L, Alam MM, Gupta A, Sharma G, Pillai B, Sengupta S. (2006). Homocysteine-and cysteine-mediated growth defect is not associated with induction of oxidative stress response genes in yeast. Biochem J 396:61-69
27. Kumar J, Das SK, Sharma P, Karthikeyan G, Ramakrishnan L, Sengupta S. (2005). Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 50:655-663
28. Lambropoulos AF, Agorastos T, Foka ZJ, Chrisafi S, Constantinidis TC, Bontis J, Kotsis A. (2003). Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 191:187-191
29. Lau AT, Wang Y, Chiu JF. (2008). Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 104:657-667
30. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102
31. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinski SM. (1989). Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214
32. Mukherjee M, Joshi S, Bagadi S, Dalvi M, Rao A, Shetty KR. (2002). A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 61:155-159
33. Ozkan Y, Yardim-Akaydin S, Firat H, Calişkan-Can E, Ardiç S, Simşek B. (2007). Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients. Anticancer Res 27:1185-1189
34. Piyathilake CJ, Azrad M, Macaluso M, Johanning GL, Cornwell PE, Partridge EE, Heimburger DC. (2007). Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition 23:229-235
35. Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC, Giuliano A. (2000). Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20:1751-1757
36. Powers HJ. (2005). Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 135 (12 suppl): 2960S-66S.
37. Rao GG, Kurien A, Gossett D, Griffith WF, Coleman RL, Muller CY. (2006). A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis. Gynecol Oncol 101:250-4.
38. Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989. p. 9.16-9.19.
39. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C. (2007). Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 67:5553-5560
40. Shekari M, Sobti RC, Kordi Tamandani DM, Suri V. (2008). Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 278:517-524
41. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q. (2001). Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95:332-336 (Pubitemid 32847046)
42. Sull JW, Jee SH, Yi S, Lee JE, Park JS, Kim S, Ohrr H. (2004).The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol 95:557-563
43. Sun CF, Haven TR, Wu TL, Tsao KC, Wu JT. (2002). Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Chim Acta 321:55-62.
44. Thomson SW, Heimburger DC, Cornwell PE, Turner ME, Sauberlich HE, Fox LM, Butterworth CE. (2000). Effect of total plasma homocysteine on cervical dysplasia risk. Nutr Cancer 37:128-133
45. Unfried G, Griesmacher A, Weismuller W, Nagele F, Huber JC, Tempfer CB. (2002). The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol 99:614-619
46. Wang J, Gajalakshmi V, Jiang J, Kuriki K, Suzuki S, Nagaya T, Nakamura S, Akasaka S, Ishikawa H, Tokudome S. (2006). Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. Int J Cancer 118:991-997
47. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172
48. Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD. (2001). Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12:317-324
49. Weinstein SJ, Gridley G, Harty LC, Diehl SR, Brown LM, Winn DM, Bravo-Otero E, Hayes RB. (2002). Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 132:762-767
50. Zhang SM, Willett WC, Selhub J, Manson JE, Colditz GA, Hankinson SE. (2003). A prospective study of plasma total cysteine and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12:1188-1193
51. Ziegler RG, Weinstein SJ, Fears TR. (2002). Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 132:2345S-49S.
52. Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, de Vries EG, te Meerman GJ, van der Zee AG. (2005). Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet 116:247-254 (Pubitemid 40277235)